| John Gendy, | |
|
10205 Tudor Ave, Montclair, CA 91763-3720 | |
| (347) 596-1012 | |
| Not Available |
| Full Name | John Gendy |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 10205 Tudor Ave, Montclair, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457898587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P2201X | Pharmacist - Ambulatory Care | 74410 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Gendy, 10205 Tudor Ave, Montclair, CA 91763-3720 Ph: (347) 596-1012 | John Gendy, 10205 Tudor Ave, Montclair, CA 91763-3720 Ph: (347) 596-1012 |
News Archive
How can damaged cardiac tissue following a heart attack best be treated with replacement muscle cells? A research team under the supervision of the University of Bonn is now presenting an innovative method on mice: Muscle replacement cells, which are to take over the function of the damaged tissue, are loaded with magnetic nanoparticles.
A new study from Educational and Psychological Measurement found that when it comes to homophobic bullying, there could be a gender gap.
Their study titled, "An Innovative Non-Pharmaceutical Intervention to Mitigate SARS-CoV02 Spread: Probability Sampling to Identify and Isolate Asymptomatic Cases," was released at the pre-publication and pre-peer review site medRxiv*.
Could short-term exposure to the average American diet increase one's risk for developing diabetes and cardiovascular disease? According to a recent study funded by the American Heart Association (AHA), researchers from New York Institute of Technology College of Osteopathic Medicine (NYITCOM) provide compelling evidence to support this hypothesis.
Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.
› Verified 3 days ago
Leon Quan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9404 Central Ave, Montclair, CA 91763 Phone: 909-575-5003 | |
Jeanette Der, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9404 Central Ave, Montclair, CA 91763 Phone: 909-575-5003 | |
Mr. Robert H Mohrmann, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9635 Monte Vista Ave #202, Montclair, CA 91763 Phone: 909-624-9633 | |
Jennifer Lew, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9052 Central Ave, Store #1423, Montclair, CA 91763 Phone: 909-447-6785 | |
Kevin Lo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4535 Holt Blvd, Montclair, CA 91763 Phone: 909-624-4177 | |
Mays Kandela, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9675 Monte Vista Ave, Montclair, CA 91763 Phone: 909-542-9365 |